These findings suggest that integrating metabolic phenotypes with CD4 stratification could refine risk assessment for tuberculosis preventive therapy in PLHIV, with underweight individuals at CD4 < 500 cells/μL representing a particularly vulnerable subgroup requiring intensified intervention. This evidence concerns the gene CD4 and tuberculosis.